Salem, Joe-Elie

Fatal Toxic Effects Associated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-analysis

Wang, D. Y., Salem, J.-E., Cohen, J. V., Chandra, S., Menzer, C., Ye, F., Zhao, S., Das, S., Beckermann, K. E., Ha, L., et al. (2018) · JAMA Oncology

Cancer Immunotherapy and BiomarkersPharmacovigilance and Adverse Drug Reactions

Cited by 2,674

Cardiovascular toxicities associated with immune checkpoint inhibitors: an observational, retrospective, pharmacovigilance study

Salem, J.-E., Manouchehri, A., Moey, M., Lebrun-Vignes, B., Bastarache, L., Pariente, A., Gobert, A., Spano, J.-P., Balko, J. M., Bonaca, M. P., et al. (2018) · The Lancet Oncology

Cancer Immunotherapy and BiomarkersPharmacovigilance and Adverse Drug Reactions

Cited by 1,271

Increased reporting of fatal immune checkpoint inhibitor-associated myocarditis

Moslehi, J. J., Salem, J.-E., Sosman, J. A., Lebrun-Vignes, B., & Johnson, D. B. (2018) · The Lancet

Cancer Immunotherapy and BiomarkersPharmacovigilance and Adverse Drug Reactions

Cited by 942

Abatacept for Severe Immune Checkpoint Inhibitor–Associated Myocarditis

Salem, J.-E., Allenbach, Y., Vozy, A., Brechot, N., Johnson, D. B., Moslehi, J. J., & Kerneis, M. (2019) · New England Journal of Medicine

Cancer Immunotherapy and BiomarkersViral Infections and Immunology Research

Cited by 443

Platelet function monitoring to adjust antiplatelet therapy in elderly patients stented for an acute coronary syndrome (ANTARCTIC): an open-label, blinded-endpoint, randomised controlled superiority trial

Cayla, G., Cuisset, T., Silvain, J., Leclercq, F., Manzo-Silberman, S., Saint-Etienne, C., Delarche, N., Bellemain-Appaix, A., Range, G., El Mahmoud, R., et al. (2016) · The Lancet

Antiplatelet Therapy and Cardiovascular DiseasesCoronary Interventions and Diagnostics

Cited by 380

A Genetic Mouse Model Recapitulates Immune Checkpoint Inhibitor–Associated Myocarditis and Supports a Mechanism-Based Therapeutic Intervention

Wei, S. C., Meijers, W. C., Axelrod, M. L., Anang, N.-A. A. S., Screever, E. M., Wescott, E. C., Johnson, D. B., Whitley, E., Lehmann, L., Courand, P.-Y., et al. (2021) · Cancer Discovery

Cancer Immunotherapy and BiomarkersViral Infections and Immunology Research

Cited by 290

Abatacept/Ruxolitinib and Screening for Concomitant Respiratory Muscle Failure to Mitigate Fatality of Immune-Checkpoint Inhibitor Myocarditis

Salem, J.-E., Bretagne, M., Abbar, B., Leonard-Louis, S., Ederhy, S., Redheuil, A., Boussouar, S., Nguyen, L. S., Procureur, A., Stein, F., et al. (2023) · Cancer Discovery

Cancer Immunotherapy and BiomarkersInflammatory Myopathies and Dermatomyositis

Cited by 243

Clinical Strategy for the Diagnosis and Treatment of Immune Checkpoint Inhibitor–Associated Myocarditis: A Narrative Review

Lehmann, L. H., Cautela, J., Palaskas, N., Baik, A. H., Meijers, W. C., Allenbach, Y., Alexandre, J., Rassaf, T., Müller, O. J., Aras, M., et al. (2021) · JAMA Cardiology

Cancer Immunotherapy and BiomarkersViral Infections and Immunology Research

Cited by 178

A case report of clonal EBV-like memory CD4+ T cell activation in fatal checkpoint inhibitor-induced encephalitis

Johnson, D. B., McDonnell, W. J., Gonzalez-Ericsson, P. I., Al-Rohil, R. N., Mobley, B. C., Salem, J.-E., Wang, D. Y., Sanchez, V., Wang, Y., Chastain, C. A., et al. (2019) · Nature Medicine

Cancer Immunotherapy and BiomarkersAutoimmune Neurological Disorders and Treatments

Cited by 176

Cardiomuscular Biomarkers in the Diagnosis and Prognostication of Immune Checkpoint Inhibitor Myocarditis

Lehmann, L. H., Heckmann, M. B., Bailly, G., Finke, D., Procureur, A., Power, J. R., Stein, F., Bretagne, M., Ederhy, S., Fenioux, C., et al. (2023) · Circulation

Cancer Immunotherapy and BiomarkersViral Infections and Immunology Research

Cited by 165

Clinical spectrum and evolution of immune-checkpoint inhibitors toxicities over a decade—a worldwide perspective

Gougis, P., Jochum, F., Abbar, B., Dumas, E., Bihan, K., Lebrun-Vignes, B., Moslehi, J., Spano, J.-P., Laas, E., Hotton, J., et al. (2024) · eClinicalMedicine

Cancer Immunotherapy and BiomarkersPharmacovigilance and Adverse Drug Reactions

Cited by 161

Impairment of gut microbial biotin metabolism and host biotin status in severe obesity: effect of biotin and prebiotic supplementation on improved metabolism

Belda, E., Voland, L., Tremaroli, V., Falony, G., Adriouch, S., Assmann, K. E., Prifti, E., Aron-Wisnewsky, J., Debédat, J., Le Roy, T., et al. (2022) · Gut

Gut microbiota and healthBiotin and Related Studies

Cited by 140

Mechanisms of Cardiovascular Toxicities Associated With Immunotherapies

Baik, A. H., Oluwole, O. O., Johnson, D. B., Shah, N., Salem, J.-E., Tsai, K. K., & Moslehi, J. J. (2021) · Circulation Research

Chemotherapy-induced cardiotoxicity and mitigationCancer Immunotherapy and Biomarkers

Cited by 138

Systematic analysis of drug-associated myocarditis reported in the World Health Organization pharmacovigilance database

Nguyen, L. S., Cooper, L. T., Kerneis, M., Funck-Brentano, C., Silvain, J., Brechot, N., Hekimian, G., Ammirati, E., Ben M’Barek, B., Redheuil, A., et al. (2022) · Nature Communications

Pharmacovigilance and Adverse Drug ReactionsViral Infections and Immunology Research

Cited by 136

Electrocardiographic Manifestations of Immune Checkpoint Inhibitor Myocarditis

Power, J. R., Alexandre, J., Choudhary, A., Ozbay, B., Hayek, S., Asnani, A., Tamura, Y., Aras, M., Cautela, J., Thuny, F., et al. (2021) · Circulation

Cancer Immunotherapy and BiomarkersViral Infections and Immunology Research

Cited by 136

Immune checkpoint inhibitor-associated primary adrenal insufficiency: WHO VigiBase report analysis

Grouthier, V., Lebrun-Vignes, B., Moey, M., Johnson, D. B., Moslehi, J. J., Salem, J.-E., & Bachelot, A. (2020) · The Oncologist

Cancer Immunotherapy and BiomarkersAdrenal Hormones and Disorders

Cited by 126

Effect of Intracoronary Administration of AAV1/SERCA2a on Ventricular Remodelling in Patients with Advanced Systolic Heart Failure: Results from the Agent-Hf Randomized Phase 2 Trial

Hulot, J.-S., Salem, J.-E., Redheuil, A., Collet, J.-P., Varnous, S., Jourdain, P., Logeart, D., Gandjbakhch, E., Bernard, C., Hatem, S. N., et al. (2017) · European Journal of Heart Failure

Virus-based gene therapy researchCardiac Fibrosis and Remodeling

Cited by 113

Thymus alterations and susceptibility to immune checkpoint inhibitor myocarditis

Fenioux, C., Abbar, B., Boussouar, S., Bretagne, M., Power, J. R., Moslehi, J. J., Gougis, P., Amelin, D., Dechartres, A., Lehmann, L. H., et al. (2023) · Nature Medicine

Cancer Immunotherapy and BiomarkersMyasthenia Gravis and Thymoma

Cited by 83

Demographic Factors Associated with Toxicity in Patients Treated with Anti-Programmed Cell Death-1 Therapy

Shah, K. P., Song, H., Ye, F., Moslehi, J. J., Balko, J. M., Salem, J.-E., & Johnson, D. B. (2020) · Cancer Immunology Research

Cancer Immunotherapy and BiomarkersPharmacovigilance and Adverse Drug Reactions

Cited by 64

Immune Checkpoint Inhibitor Myocarditis Treatment Strategies and Future Directions

Moslehi, J., & Salem, J.-E. (2022) · JACC: CardioOncology

Cancer Immunotherapy and BiomarkersChemotherapy-induced cardiotoxicity and mitigation

Cited by 59

Association of early electrical changes with cardiovascular outcomes in immune checkpoint inhibitor myocarditis

Power, J. R., Alexandre, J., Choudhary, A., Ozbay, B., Hayek, S. S., Asnani, A., Tamura, Y., Aras, M., Cautela, J., Thuny, F., et al. (2022) · Archives of Cardiovascular Diseases

Viral Infections and Immunology ResearchCancer Immunotherapy and Biomarkers

Cited by 43

Antiphospholipid antibodies and thrombotic events in COVID-19 patients hospitalized in medicine ward

Le Joncour, A., Frere, C., Martin-Toutain, I., Gougis, P., Ghillani-Dalbin, P., Maalouf, G., Vieira, M., Marcelin, A.-G., Salem, J.-E., Allenbach, Y., et al. (2021) · Autoimmunity Reviews

Systemic Lupus Erythematosus ResearchCOVID-19 Clinical Research Studies

Cited by 37

Complex association of sex hormones on left ventricular systolic function: insight into sexual dimorphism

Salem, J.-E., Nguyen, L. S., Hammoudi, N., Preud'homme, G., Hulot, J.-S., Leban, M., Funck-Brentano, C., Touraine, P., Isnard, R., Bachelot, A., et al. (2018) · Journal of the American Society of Echocardiography

Cardiovascular Function and Risk FactorsHormonal and reproductive studies

Cited by 17

Early central blood pressure elevation in adult patients with 21-hydroxylase deficiency

Rosenbaum, D., Gallo, A., Lethielleux, G., Bruckert, E., Levy, B. I., Tanguy, M. L., Dulon, J., Dahmoune, N., Salem, J. E., Bittar, R., et al. (2019) · Journal of Hypertension

Sexual Differentiation and DisordersAdrenal Hormones and Disorders

Cited by 15